Education
About Us
Working with TipRanks
Follow Us
Hisamitsu Pharmaceutical Co (JP:4530)
OTHER OTC:4530
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 156.01B | ¥ 141.71B | ¥ 128.33B | ¥ 120.19B | ¥ 114.51B |
| Gross Profit | ¥ 91.20B | ¥ 78.97B | ¥ 72.70B | ¥ 70.07B | ¥ 69.17B |
| Operating Income | ¥ 18.89B | ¥ 13.17B | ¥ 11.60B | ¥ 9.34B | ¥ 10.67B |
| EBITDA | ¥ 35.05B | ¥ 24.38B | ¥ 21.08B | ¥ 17.30B | ¥ 16.29B |
| Net Income | ¥ 21.76B | ¥ 13.97B | ¥ 11.74B | ¥ 9.66B | ¥ 9.25B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 129.12B | ¥ 125.32B | ¥ 136.87B | ¥ 142.43B | ¥ 136.00B |
| Total Assets | ¥ 343.07B | ¥ 328.78B | ¥ 313.92B | ¥ 302.86B | ¥ 299.86B |
| Total Debt | ¥ 3.86B | ¥ 2.10B | ¥ 2.29B | ¥ 2.46B | ¥ 1.60B |
| Net Debt | ¥ -110.66B | ¥ -110.36B | ¥ -119.86B | ¥ -126.83B | ¥ -112.65B |
| Total Liabilities | ¥ 63.66B | ¥ 61.70B | ¥ 55.51B | ¥ 47.98B | ¥ 46.06B |
| Stockholders' Equity | ¥ 276.82B | ¥ 264.87B | ¥ 256.36B | ¥ 253.16B | ¥ 252.29B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 4.99B | ¥ 5.15B | ¥ 4.82B | ¥ 15.01B | ¥ 1.90B |
| Operating Cash Flow | ¥ 18.77B | ¥ 18.19B | ¥ 12.73B | ¥ 19.20B | ¥ 5.29B |
| Investing Cash Flow | ¥ 17.56B | ¥ -2.51B | ¥ -23.87B | ¥ -13.06B | ¥ 7.82B |
| Financing Cash Flow | ¥ -15.85B | ¥ -16.69B | ¥ -14.69B | ¥ -15.19B | ¥ -7.19B |